Nimesulide patent gel Nimulid for Acute pain

A brand from Nimesulide Transdermal Gel, reffered as a Nimulid Transgel within which the composition contains 10mg of nimsulide in each gram of Nimulid. Nimesulide gel preparations for localized topical application are indicated for the treatment of symptomatic relief of pain associated with sprains and acute traumatic tendinitis. Nimullid Transgel is indicated for post-traumatic inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness. The dose needed to be applied is three to four times per day depending on the dimension of the affected size and response. Medicalcare ought to be reviewed after 4 weeks. In addition to medicament activity of Nimulid Transgel is also evaluated for primary skin irritation, eye irritation and photo toxicity in rabbits. Nimulid Transgel doesn’t cause allergic manifestation, reddening etc.